1 Study Coverage
    1.1 Mebeverine Product Introduction
    1.2 Market by Type
        1.2.1 Global Mebeverine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Capsule
        1.2.3 Tablet
    1.3 Market by Application
        1.3.1 Global Mebeverine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Drug Store
        1.3.4 On-line
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Mebeverine Sales Estimates and Forecasts 2017-2028
    2.2 Global Mebeverine Revenue Estimates and Forecasts 2017-2028
    2.3 Global Mebeverine Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Mebeverine Sales by Region
        2.4.1 Global Mebeverine Sales by Region (2017-2022)
        2.4.2 Global Sales Mebeverine by Region (2023-2028)
    2.5 Global Mebeverine Revenue by Region
        2.5.1 Global Mebeverine Revenue by Region (2017-2022)
        2.5.2 Global Mebeverine Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Mebeverine Sales by Manufacturers
        3.1.1 Global Top Mebeverine Manufacturers by Sales (2017-2022)
        3.1.2 Global Mebeverine Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Mebeverine in 2021
    3.2 Global Mebeverine Revenue by Manufacturers
        3.2.1 Global Mebeverine Revenue by Manufacturers (2017-2022)
        3.2.2 Global Mebeverine Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Mebeverine Revenue in 2021
    3.3 Global Mebeverine Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Mebeverine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Mebeverine Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Mebeverine Sales by Type
        4.1.1 Global Mebeverine Historical Sales by Type (2017-2022)
        4.1.2 Global Mebeverine Forecasted Sales by Type (2023-2028)
        4.1.3 Global Mebeverine Sales Market Share by Type (2017-2028)
    4.2 Global Mebeverine Revenue by Type
        4.2.1 Global Mebeverine Historical Revenue by Type (2017-2022)
        4.2.2 Global Mebeverine Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Mebeverine Revenue Market Share by Type (2017-2028)
    4.3 Global Mebeverine Price by Type
        4.3.1 Global Mebeverine Price by Type (2017-2022)
        4.3.2 Global Mebeverine Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Mebeverine Sales by Application
        5.1.1 Global Mebeverine Historical Sales by Application (2017-2022)
        5.1.2 Global Mebeverine Forecasted Sales by Application (2023-2028)
        5.1.3 Global Mebeverine Sales Market Share by Application (2017-2028)
    5.2 Global Mebeverine Revenue by Application
        5.2.1 Global Mebeverine Historical Revenue by Application (2017-2022)
        5.2.2 Global Mebeverine Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Mebeverine Revenue Market Share by Application (2017-2028)
    5.3 Global Mebeverine Price by Application
        5.3.1 Global Mebeverine Price by Application (2017-2022)
        5.3.2 Global Mebeverine Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Mebeverine Market Size by Type
        6.1.1 North America Mebeverine Sales by Type (2017-2028)
        6.1.2 North America Mebeverine Revenue by Type (2017-2028)
    6.2 North America Mebeverine Market Size by Application
        6.2.1 North America Mebeverine Sales by Application (2017-2028)
        6.2.2 North America Mebeverine Revenue by Application (2017-2028)
    6.3 North America Mebeverine Market Size by Country
        6.3.1 North America Mebeverine Sales by Country (2017-2028)
        6.3.2 North America Mebeverine Revenue by Country (2017-2028)
        6.3.3 United States
        6.3.4 Canada
7 Europe
    7.1 Europe Mebeverine Market Size by Type
        7.1.1 Europe Mebeverine Sales by Type (2017-2028)
        7.1.2 Europe Mebeverine Revenue by Type (2017-2028)
    7.2 Europe Mebeverine Market Size by Application
        7.2.1 Europe Mebeverine Sales by Application (2017-2028)
        7.2.2 Europe Mebeverine Revenue by Application (2017-2028)
    7.3 Europe Mebeverine Market Size by Country
        7.3.1 Europe Mebeverine Sales by Country (2017-2028)
        7.3.2 Europe Mebeverine Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Mebeverine Market Size by Type
        8.1.1 Asia Pacific Mebeverine Sales by Type (2017-2028)
        8.1.2 Asia Pacific Mebeverine Revenue by Type (2017-2028)
    8.2 Asia Pacific Mebeverine Market Size by Application
        8.2.1 Asia Pacific Mebeverine Sales by Application (2017-2028)
        8.2.2 Asia Pacific Mebeverine Revenue by Application (2017-2028)
    8.3 Asia Pacific Mebeverine Market Size by Region
        8.3.1 Asia Pacific Mebeverine Sales by Region (2017-2028)
        8.3.2 Asia Pacific Mebeverine Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Mebeverine Market Size by Type
        9.1.1 Latin America Mebeverine Sales by Type (2017-2028)
        9.1.2 Latin America Mebeverine Revenue by Type (2017-2028)
    9.2 Latin America Mebeverine Market Size by Application
        9.2.1 Latin America Mebeverine Sales by Application (2017-2028)
        9.2.2 Latin America Mebeverine Revenue by Application (2017-2028)
    9.3 Latin America Mebeverine Market Size by Country
        9.3.1 Latin America Mebeverine Sales by Country (2017-2028)
        9.3.2 Latin America Mebeverine Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Mebeverine Market Size by Type
        10.1.1 Middle East and Africa Mebeverine Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Mebeverine Revenue by Type (2017-2028)
    10.2 Middle East and Africa Mebeverine Market Size by Application
        10.2.1 Middle East and Africa Mebeverine Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Mebeverine Revenue by Application (2017-2028)
    10.3 Middle East and Africa Mebeverine Market Size by Country
        10.3.1 Middle East and Africa Mebeverine Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Mebeverine Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Abbott
        11.1.1 Abbott Corporation Information
        11.1.2 Abbott Overview
        11.1.3 Abbott Mebeverine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Abbott Mebeverine Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Abbott Recent Developments
    11.2 Mylan
        11.2.1 Mylan Corporation Information
        11.2.2 Mylan Overview
        11.2.3 Mylan Mebeverine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Mylan Mebeverine Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Mylan Recent Developments
    11.3 Greville Investing Limited
        11.3.1 Greville Investing Limited Corporation Information
        11.3.2 Greville Investing Limited Overview
        11.3.3 Greville Investing Limited Mebeverine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Greville Investing Limited Mebeverine Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Greville Investing Limited Recent Developments
    11.4 Expanscience
        11.4.1 Expanscience Corporation Information
        11.4.2 Expanscience Overview
        11.4.3 Expanscience Mebeverine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Expanscience Mebeverine Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Expanscience Recent Developments
    11.5 Berlin Pharmaceutical
        11.5.1 Berlin Pharmaceutical Corporation Information
        11.5.2 Berlin Pharmaceutical Overview
        11.5.3 Berlin Pharmaceutical Mebeverine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Berlin Pharmaceutical Mebeverine Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Berlin Pharmaceutical Recent Developments
    11.6 Eipico Pharmaceutical
        11.6.1 Eipico Pharmaceutical Corporation Information
        11.6.2 Eipico Pharmaceutical Overview
        11.6.3 Eipico Pharmaceutical Mebeverine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Eipico Pharmaceutical Mebeverine Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Eipico Pharmaceutical Recent Developments
    11.7 Sopharma
        11.7.1 Sopharma Corporation Information
        11.7.2 Sopharma Overview
        11.7.3 Sopharma Mebeverine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Sopharma Mebeverine Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Sopharma Recent Developments
    11.8 USV Private Limited
        11.8.1 USV Private Limited Corporation Information
        11.8.2 USV Private Limited Overview
        11.8.3 USV Private Limited Mebeverine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 USV Private Limited Mebeverine Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 USV Private Limited Recent Developments
    11.9 Puren Pharma
        11.9.1 Puren Pharma Corporation Information
        11.9.2 Puren Pharma Overview
        11.9.3 Puren Pharma Mebeverine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Puren Pharma Mebeverine Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Puren Pharma Recent Developments
    11.10 Pharco
        11.10.1 Pharco Corporation Information
        11.10.2 Pharco Overview
        11.10.3 Pharco Mebeverine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Pharco Mebeverine Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Pharco Recent Developments
    11.11 Swiss Pharm
        11.11.1 Swiss Pharm Corporation Information
        11.11.2 Swiss Pharm Overview
        11.11.3 Swiss Pharm Mebeverine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Swiss Pharm Mebeverine Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Swiss Pharm Recent Developments
    11.12 Dr. Reddy's
        11.12.1 Dr. Reddy's Corporation Information
        11.12.2 Dr. Reddy's Overview
        11.12.3 Dr. Reddy's Mebeverine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Dr. Reddy's Mebeverine Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Dr. Reddy's Recent Developments
    11.13 Aurovitas Pharma
        11.13.1 Aurovitas Pharma Corporation Information
        11.13.2 Aurovitas Pharma Overview
        11.13.3 Aurovitas Pharma Mebeverine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Aurovitas Pharma Mebeverine Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Aurovitas Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Mebeverine Industry Chain Analysis
    12.2 Mebeverine Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Mebeverine Production Mode & Process
    12.4 Mebeverine Sales and Marketing
        12.4.1 Mebeverine Sales Channels
        12.4.2 Mebeverine Distributors
    12.5 Mebeverine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Mebeverine Industry Trends
    13.2 Mebeverine Market Drivers
    13.3 Mebeverine Market Challenges
    13.4 Mebeverine Market Restraints
14 Key Findings in The Global Mebeverine Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Mebeverine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Capsule
    Table 3. Major Manufacturers of Tablet
    Table 4. Global Mebeverine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Mebeverine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Mebeverine Sales by Region (2017-2022) & (K Units)
    Table 7. Global Mebeverine Sales Market Share by Region (2017-2022)
    Table 8. Global Mebeverine Sales by Region (2023-2028) & (K Units)
    Table 9. Global Mebeverine Sales Market Share by Region (2023-2028)
    Table 10. Global Mebeverine Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Mebeverine Revenue Market Share by Region (2017-2022)
    Table 12. Global Mebeverine Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Mebeverine Revenue Market Share by Region (2023-2028)
    Table 14. Global Mebeverine Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Mebeverine Sales Share by Manufacturers (2017-2022)
    Table 16. Global Mebeverine Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Mebeverine Revenue Share by Manufacturers (2017-2022)
    Table 18. Mebeverine Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 19. Global Mebeverine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Mebeverine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mebeverine as of 2021)
    Table 21. Mebeverine Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Mebeverine Product Offered
    Table 23. Date of Manufacturers Enter into Mebeverine Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Mebeverine Sales by Type (2017-2022) & (K Units)
    Table 26. Global Mebeverine Sales by Type (2023-2028) & (K Units)
    Table 27. Global Mebeverine Sales Share by Type (2017-2022)
    Table 28. Global Mebeverine Sales Share by Type (2023-2028)
    Table 29. Global Mebeverine Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Mebeverine Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Mebeverine Revenue Share by Type (2017-2022)
    Table 32. Global Mebeverine Revenue Share by Type (2023-2028)
    Table 33. Mebeverine Price by Type (2017-2022) & (US$/Unit)
    Table 34. Global Mebeverine Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 35. Global Mebeverine Sales by Application (2017-2022) & (K Units)
    Table 36. Global Mebeverine Sales by Application (2023-2028) & (K Units)
    Table 37. Global Mebeverine Sales Share by Application (2017-2022)
    Table 38. Global Mebeverine Sales Share by Application (2023-2028)
    Table 39. Global Mebeverine Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Mebeverine Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Mebeverine Revenue Share by Application (2017-2022)
    Table 42. Global Mebeverine Revenue Share by Application (2023-2028)
    Table 43. Mebeverine Price by Application (2017-2022) & (US$/Unit)
    Table 44. Global Mebeverine Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 45. North America Mebeverine Sales by Type (2017-2022) & (K Units)
    Table 46. North America Mebeverine Sales by Type (2023-2028) & (K Units)
    Table 47. North America Mebeverine Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Mebeverine Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Mebeverine Sales by Application (2017-2022) & (K Units)
    Table 50. North America Mebeverine Sales by Application (2023-2028) & (K Units)
    Table 51. North America Mebeverine Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Mebeverine Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Mebeverine Sales by Country (2017-2022) & (K Units)
    Table 54. North America Mebeverine Sales by Country (2023-2028) & (K Units)
    Table 55. North America Mebeverine Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Mebeverine Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Mebeverine Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Mebeverine Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Mebeverine Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Mebeverine Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Mebeverine Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Mebeverine Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Mebeverine Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Mebeverine Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Mebeverine Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Mebeverine Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Mebeverine Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Mebeverine Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Mebeverine Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Mebeverine Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Mebeverine Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Mebeverine Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Mebeverine Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Mebeverine Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Mebeverine Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Mebeverine Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Mebeverine Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Mebeverine Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Mebeverine Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Mebeverine Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Mebeverine Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Mebeverine Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Mebeverine Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Mebeverine Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Mebeverine Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Mebeverine Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Mebeverine Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Mebeverine Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Mebeverine Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Mebeverine Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Mebeverine Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Mebeverine Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Mebeverine Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Mebeverine Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Mebeverine Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Mebeverine Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Mebeverine Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Mebeverine Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Mebeverine Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Mebeverine Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Mebeverine Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Mebeverine Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Mebeverine Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Mebeverine Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Abbott Corporation Information
    Table 106. Abbott Description and Major Businesses
    Table 107. Abbott Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 108. Abbott Mebeverine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Abbott Recent Developments
    Table 110. Mylan Corporation Information
    Table 111. Mylan Description and Major Businesses
    Table 112. Mylan Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 113. Mylan Mebeverine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Mylan Recent Developments
    Table 115. Greville Investing Limited Corporation Information
    Table 116. Greville Investing Limited Description and Major Businesses
    Table 117. Greville Investing Limited Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 118. Greville Investing Limited Mebeverine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Greville Investing Limited Recent Developments
    Table 120. Expanscience Corporation Information
    Table 121. Expanscience Description and Major Businesses
    Table 122. Expanscience Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 123. Expanscience Mebeverine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Expanscience Recent Developments
    Table 125. Berlin Pharmaceutical Corporation Information
    Table 126. Berlin Pharmaceutical Description and Major Businesses
    Table 127. Berlin Pharmaceutical Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 128. Berlin Pharmaceutical Mebeverine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Berlin Pharmaceutical Recent Developments
    Table 130. Eipico Pharmaceutical Corporation Information
    Table 131. Eipico Pharmaceutical Description and Major Businesses
    Table 132. Eipico Pharmaceutical Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 133. Eipico Pharmaceutical Mebeverine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Eipico Pharmaceutical Recent Developments
    Table 135. Sopharma Corporation Information
    Table 136. Sopharma Description and Major Businesses
    Table 137. Sopharma Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 138. Sopharma Mebeverine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Sopharma Recent Developments
    Table 140. USV Private Limited Corporation Information
    Table 141. USV Private Limited Description and Major Businesses
    Table 142. USV Private Limited Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 143. USV Private Limited Mebeverine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. USV Private Limited Recent Developments
    Table 145. Puren Pharma Corporation Information
    Table 146. Puren Pharma Description and Major Businesses
    Table 147. Puren Pharma Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 148. Puren Pharma Mebeverine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Puren Pharma Recent Developments
    Table 150. Pharco Corporation Information
    Table 151. Pharco Description and Major Businesses
    Table 152. Pharco Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 153. Pharco Mebeverine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Pharco Recent Developments
    Table 155. Swiss Pharm Corporation Information
    Table 156. Swiss Pharm Description and Major Businesses
    Table 157. Swiss Pharm Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 158. Swiss Pharm Mebeverine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Swiss Pharm Recent Developments
    Table 160. Dr. Reddy's Corporation Information
    Table 161. Dr. Reddy's Description and Major Businesses
    Table 162. Dr. Reddy's Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 163. Dr. Reddy's Mebeverine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. Dr. Reddy's Recent Developments
    Table 165. Aurovitas Pharma Corporation Information
    Table 166. Aurovitas Pharma Description and Major Businesses
    Table 167. Aurovitas Pharma Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 168. Aurovitas Pharma Mebeverine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 169. Aurovitas Pharma Recent Developments
    Table 170. Key Raw Materials Lists
    Table 171. Raw Materials Key Suppliers Lists
    Table 172. Mebeverine Distributors List
    Table 173. Mebeverine Customers List
    Table 174. Mebeverine Market Trends
    Table 175. Mebeverine Market Drivers
    Table 176. Mebeverine Market Challenges
    Table 177. Mebeverine Market Restraints
    Table 178. Research Programs/Design for This Report
    Table 179. Key Data Information from Secondary Sources
    Table 180. Key Data Information from Primary Sources
List of Figures
    Figure 1. Mebeverine Product Picture
    Figure 3. Global Mebeverine Market Share by Type in 2021 & 2028
    Figure 3. Capsule Product Picture
    Figure 4. Tablet Product Picture
    Figure 5. Global Mebeverine Market Share by Application in 2021 & 2028
    Figure 6. Hospital
    Figure 7. Drug Store
    Figure 8. On-line
    Figure 9. Mebeverine Report Years Considered
    Figure 10. Global Mebeverine Sales 2017-2028 (K Units)
    Figure 11. Global Mebeverine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Mebeverine Revenue 2017-2028 (US$ Million)
    Figure 13. Global Mebeverine Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Mebeverine Sales Market Share by Region (2017-2022)
    Figure 15. Global Mebeverine Sales Market Share by Region (2023-2028)
    Figure 16. North America Mebeverine Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Mebeverine Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Mebeverine Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Mebeverine Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Mebeverine Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Mebeverine Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Mebeverine Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Mebeverine Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Mebeverine Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Mebeverine Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Mebeverine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Mebeverine in the World: Market Share by Mebeverine Revenue in 2021
    Figure 28. Global Mebeverine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Mebeverine Sales Market Share by Type (2017-2028)
    Figure 30. Global Mebeverine Revenue Market Share by Type (2017-2028)
    Figure 31. Global Mebeverine Sales Market Share by Application (2017-2028)
    Figure 32. Global Mebeverine Revenue Market Share by Application (2017-2028)
    Figure 33. North America Mebeverine Sales Market Share by Type (2017-2028)
    Figure 34. North America Mebeverine Revenue Market Share by Type (2017-2028)
    Figure 35. North America Mebeverine Sales Market Share by Application (2017-2028)
    Figure 36. North America Mebeverine Revenue Market Share by Application (2017-2028)
    Figure 37. North America Mebeverine Sales Share by Country (2017-2028)
    Figure 38. North America Mebeverine Revenue Share by Country (2017-2028)
    Figure 39. United States Mebeverine Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Mebeverine Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Mebeverine Sales Market Share by Type (2017-2028)
    Figure 42. Europe Mebeverine Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Mebeverine Sales Market Share by Application (2017-2028)
    Figure 44. Europe Mebeverine Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Mebeverine Sales Share by Country (2017-2028)
    Figure 46. Europe Mebeverine Revenue Share by Country (2017-2028)
    Figure 47. Germany Mebeverine Revenue (2017-2028) & (US$ Million)
    Figure 48. France Mebeverine Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Mebeverine Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Mebeverine Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Mebeverine Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Mebeverine Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Mebeverine Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Mebeverine Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Mebeverine Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Mebeverine Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Mebeverine Revenue Share by Region (2017-2028)
    Figure 58. China Mebeverine Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Mebeverine Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Mebeverine Revenue (2017-2028) & (US$ Million)
    Figure 61. India Mebeverine Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Mebeverine Revenue (2017-2028) & (US$ Million)
    Figure 63. China Taiwan Mebeverine Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Mebeverine Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Mebeverine Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Mebeverine Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Mebeverine Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Mebeverine Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Mebeverine Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Mebeverine Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Mebeverine Sales Share by Country (2017-2028)
    Figure 72. Latin America Mebeverine Revenue Share by Country (2017-2028)
    Figure 73. Mexico Mebeverine Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Mebeverine Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Mebeverine Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Mebeverine Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Mebeverine Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Mebeverine Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Mebeverine Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Mebeverine Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa Mebeverine Revenue Share by Country (2017-2028)
    Figure 82. Turkey Mebeverine Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia Mebeverine Revenue (2017-2028) & (US$ Million)
    Figure 84. UAE Mebeverine Revenue (2017-2028) & (US$ Million)
    Figure 85. Mebeverine Value Chain
    Figure 86. Mebeverine Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed